PANRETIN is a Topical Gel in the Human Prescription Drug category. It is labeled and distributed by Concordia Pharmaceuticals Inc.. The primary component is Alitretinoin.
| Product ID | 59212-601_1629bcf4-47bc-4203-878f-c7daeb6e8fc7 | 
| NDC | 59212-601 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | PANRETIN | 
| Generic Name | Alitretinoin | 
| Dosage Form | Gel | 
| Route of Administration | TOPICAL | 
| Marketing Start Date | 2019-09-10 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA020886 | 
| Labeler Name | Concordia Pharmaceuticals Inc. | 
| Substance Name | ALITRETINOIN | 
| Active Ingredient Strength | 60 mg/60g | 
| Pharm Classes | Retinoid [EPC],Retinoids [CS] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2022-12-31 | 
| Marketing Start Date | 2019-09-10 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA020886 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2019-09-10 | 
| Ingredient | Strength | 
|---|---|
| ALITRETINOIN | 60 mg/60g | 
| SPL SET ID: | 49c16717-7d86-4257-80c9-baa1417e5555 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 59212-601 | PANRETIN | alitretinoin | 
| 62856-601 | Panretin | Alitretinoin | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  PANRETIN  74700355  2149627 Live/Registered | EISAI INC. 1995-07-12 |